Lupin’s wholly owned subsidiary -- Lupin Healthcare (UK) has acquired Renascience Pharma (Renascience), a United Kingdom (UK)-based pharmaceutical company and sole supplier of 4 specialty products targeting unmet medical needs in the UK.
With this acquisition, Lupin Healthcare (UK) gains full ownership of Renascience which, going forward, will trade as its subsidiary. The portfolio includes branded injectable cephalosporines for infectious diseases, a topical treatment for ear pain and a branded quinazoline-like diuretic for cardiovascular and renal indications.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
